Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: March 28, 2024
Abstract
Enhancement
of
wakefulness
is
a
prerequisite
for
adaptive
behaviors
to
cope
with
acute
stress,
but
hyperarousal
associated
impaired
behavioral
performance.
Although
the
neural
circuitries
promoting
in
stress
conditions
have
been
extensively
identified,
less
known
about
circuit
mechanisms
constraining
prevent
hyperarousal.
Here,
we
found
that
chemogenetic
or
optogenetic
activation
GAD2-positive
GABAergic
neurons
midbrain
dorsal
raphe
nucleus
(DRN
GAD2
)
decreased
wakefulness,
while
inhibition
ablation
these
produced
an
increase
along
hyperactivity.
Surprisingly,
DRN
were
paradoxically
wakefulness-active
and
further
activated
by
stress.
Bidirectional
manipulations
revealed
constrained
arousal
level
mouse
model
Circuit-specific
investigations
demonstrated
via
wakefulness-promoting
paraventricular
thalamus.
Therefore,
present
study
identified
wakefulness-constraining
role
conditions.
Posttraumatic
stress
disorder
(PTSD)
is
a
serious
psychosis
leading
to
cognitive
impairment.
To
restore
functions
for
patients,
the
main
treatments
are
based
on
medication
or
rehabilitation
training
but
with
limited
effectiveness
and
strong
side
effects.
Here,
we
demonstrate
new
treatment
approach
PTSD
by
using
terahertz
(THz)
photons
stimulating
hippocampal
CA3
subregion.
We
verified
that
this
method
can
nonthermally
function
in
rats
vivo.
After
THz
photon
irradiation,
rats’
recognitive
index
improved
about
10%
novel
object
recognition
test,
accuracy
100%
shuttler
box
numbers
identify
target
was
5
times
lower
Barnes
maze
rate
of
staying
arm
increased
approximately
40%
Y-maze
test.
Further
experimental
studies
found
(34.5
THz)
irradiation
could
improve
expression
NR2B
(increased
nearly
40%)
phosphorylated
50%).
In
addition,
molecular
dynamics
simulations
showed
at
frequency
34.5
mainly
absorbed
pocket
glutamate
receptors
rather
than
molecules.
Moreover,
binding
between
molecules
photons.
This
study
offers
nondrug,
nonthermal
regulate
excitatory
neurotransmitter
(glutamate)
NR2B.
By
increasing
synaptic
plasticity,
it
effectively
improves
animals
PTSD,
providing
promising
strategy
NR2B-related
disorders.
Current Neuropharmacology,
Journal Year:
2024,
Volume and Issue:
22(4), P. 636 - 735
Published: Jan. 5, 2024
Post-traumatic
stress
disorder
(PTSD)
is
a
mental
health
condition
that
can
occur
following
exposure
to
traumatic
experience.
An
estimated
12
million
U.S.
adults
are
presently
affected
by
this
disorder.
Current
treatments
include
psychological
therapies
(e.g.,
exposure-based
interventions)
and
pharmacological
selective
serotonin
reuptake
inhibitors
(SSRIs)).
However,
significant
proportion
of
patients
receiving
standard-of-care
for
PTSD
remain
symptomatic,
new
approaches
other
trauma-related
conditions
greatly
needed.
Psychedelic
compounds
alter
cognition,
perception,
mood
currently
being
examined
their
efficacy
in
treating
despite
current
status
as
Drug
Enforcement
Administration
(DEA)-
scheduled
substances.
Initial
clinical
trials
have
demonstrated
the
potential
value
psychedelicassisted
therapy
treat
psychiatric
disorders.
In
comprehensive
review,
we
summarize
state
science
care,
including
shortcomings.
We
review
studies
psychedelic
interventions
PTSD,
disorders,
common
comorbidities.
The
classic
psychedelics
psilocybin,
lysergic
acid
diethylamide
(LSD),
N,N-dimethyltryptamine
(DMT)
DMT-containing
ayahuasca,
well
entactogen
3,4-methylenedioxymethamphetamine
(MDMA)
dissociative
anesthetic
ketamine,
reviewed.
For
each
drug,
present
history
use,
somatic
effects,
pharmacology,
safety
profile.
rationale
proposed
mechanisms
use
traumarelated
disorders
discussed.
This
concludes
with
an
in-depth
consideration
future
directions
applications
maximize
therapeutic
benefit
minimize
risk
individuals
communities
impacted
conditions.
World Psychiatry,
Journal Year:
2025,
Volume and Issue:
24(1), P. 52 - 80
Published: Jan. 15, 2025
The
understanding
of
responses
to
traumatic
events
has
been
greatly
influenced
by
the
introduction
diagnosis
post‐traumatic
stress
disorder
(PTSD).
In
this
paper
we
review
initial
versions
diagnostic
criteria
for
condition
and
associated
epidemiological
findings,
including
sociocultural
differences.
We
consider
evidence
reactions
occurring
in
multiple
contexts
not
previously
defined
as
traumatic,
implications
that
these
observations
have
diagnosis.
More
recent
developments
such
DSM‐5
dissociative
subtype
ICD‐11
complex
PTSD
are
reviewed,
adding
there
several
distinct
phenotypes.
describe
psychological
foundations
PTSD,
involving
disturbances
memory
well
identity.
A
broader
focus
on
identity
may
be
able
accommodate
group
communal
influences
experience
trauma
impact
resource
loss.
then
summarize
current
concerning
biological
with
a
particular
genetic
neuroimaging
studies.
Whereas
progress
prevention
disappointing,
is
now
an
extensive
supporting
efficacy
variety
treatments
established
trauma‐focused
interventions
–
cognitive
behavior
therapy
(TF‐CBT)
eye
movement
desensitization
reprocessing
(EMDR)
non‐trauma‐focused
therapies,
which
also
include
some
emerging
identity‐based
approaches
present‐centered
compassion‐focused
therapies.
Additionally,
promising
neither
nor
pharmacological,
or
combine
pharmacological
approach,
3,4‐methylenedioxymethamphetamine
(MDMA)‐assisted
psychotherapy.
advances
priority
areas
adapting
resource‐limited
settings
across
cultural
contexts,
community‐based
approaches.
conclude
identifying
future
directions
work
mental
health.
Neuropharmacology,
Journal Year:
2023,
Volume and Issue:
226, P. 109418 - 109418
Published: Jan. 6, 2023
Psychiatric
disorders
associated
with
psychological
trauma,
stress
and
anxiety
are
a
highly
prevalent
increasing
cause
of
morbidity
worldwide.
Current
therapeutic
approaches,
including
medication,
effective
in
alleviating
symptoms
posttraumatic
disorder
(PTSD),
at
least
some
individuals,
but
have
unwanted
side-effects
do
not
resolve
underlying
pathophysiology.
After
period
stagnation,
there
is
renewed
enthusiasm
from
public,
academic
commercial
parties
designing
developing
drug
treatments
for
these
disorders.
Here,
we
aim
to
provide
snapshot
the
current
state
this
field
that
written
neuropharmacologists,
also
practicing
clinicians
interested
lay-reader.
introducing
currently
available
treatments,
summarize
recent/ongoing
clinical
assessment
novel
medicines
PTSD,
grouped
according
primary
neurochemical
targets
their
potential
produce
acute
and/or
enduring
effects.
The
evaluation
putative
targeting
monoamine
(including
psychedelics),
GABA,
glutamate,
cannabinoid,
cholinergic
neuropeptide
systems,
amongst
others,
discussed.
We
emphasize
importance
clinically
assessing
new
medications
based
on
firm
understanding
neurobiology
stemming
rapid
advances
being
made
neuroscience.
This
includes
harnessing
neuroplasticity
bring
about
lasting
beneficial
changes
brain
rather
than
–
as
many
transient
attenuation
symptoms,
exemplified
by
combining
psychotropic/cognitive
enhancing
drugs
psychotherapeutic
approaches.
conclude
noting
other
emerging
trends
promising
phase
development.
Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: Oct. 17, 2023
Traumatic
events
result
in
vivid
and
enduring
fear
memories.
Suppressing
the
retrieval
of
these
memories
is
central
to
behavioral
therapies
for
pathological
fear.
The
medial
prefrontal
cortex
(mPFC)
hippocampus
(HPC)
have
been
implicated
suppression,
but
how
mPFC-HPC
activity
coordinated
during
extinction
unclear.
Here
we
show
that
after
training,
coherent
theta
oscillations
(6-9
Hz)
HPC
mPFC
are
correlated
with
suppression
conditioned
freezing
male
female
rats.
Inactivation
nucleus
reuniens
(RE),
a
thalamic
hub
interconnecting
HPC,
reduces
extinction-related
Fos
expression
both
dampens
coherence,
impairs
retrieval.
Conversely,
theta-paced
optogenetic
stimulation
RE
augments
relapse
extinguished
Collectively,
results
demonstrate
role
coordinating
interactions
suppress
extinction.
BMC Psychiatry,
Journal Year:
2023,
Volume and Issue:
23(1)
Published: April 10, 2023
Posttraumatic
Stress
Disorder
(PTSD)
could
potentially
increase
the
risk
of
mortality,
and
there
is
a
need
for
meta-analysis
to
quantify
this
association.
This
study
aims
determine
extent
which
PTSD
predictor
mortality.
Interdisciplinary Rehabilitation / Rehabilitacion Interdisciplinaria,
Journal Year:
2023,
Volume and Issue:
3, P. 60 - 60
Published: Sept. 24, 2023
Stress
caused
by
working
conditions
or
environments
continues
to
be
a
scourge
that
affects
workers
worldwide
and
can
affect
physical
mental
health,
even
favoring
the
emergence
of
somatic,
endocrine,
psychiatric
diseases.
In
education,
especially
teachers
who
work
directly
with
students
school
maladjustments,
learning
disorders,
which
require
greater
effort
in
teaching-learning
process,
long
hours
constant
demands
are
exposed
permanent
sources
stress
at
work.
The
paper
describes
psychological
problems
educational
sector
offers
preventive
measures
avoid
it.
Frontiers in Public Health,
Journal Year:
2024,
Volume and Issue:
12
Published: March 14, 2024
Introduction
Fleeing
from
war
can
be
terrifying
and
result
in
Acute
Stress
Disorder
(ASD),
a
mental
health
condition
that
occur
the
first
month
after
traumatic
event.
The
study
aimed
to
identify
prevalence
of
ASD
among
Ukrainian
refugees
its
risk
factors
create
profile
most
vulnerable
refugees.
Methods
This
cross-sectional
637
war-displaced
persons
2022
used
Scale.
Results
participants
was
high
(93.5%).
Several
increasing
developing
sample
were
identified,
e.g.,
witnessing
Russian
attacks
(OR
2.92,
95%
CI
1.26–6.78),
insufficient
financial
resources
3.56,
1.61–7.91),
feeling
loneliness
host
country
3.07,
1.58–8.69).
Pre-existing
depression
death
close
person,
others,
found
significantly
(
p
<
0.05)
exacerbate
symptoms.
At
same
time,
neither
age,
distance
traveled,
time
spent
on
fleeing
country,
nor
type
companionship
during
refuge
(escaping
alone,
with
children,
pets
or
older
adults)
correlate
severity
Conclusion
shows
extreme
levels
trauma
displaced
persons.
Knowledge
regarding
vulnerabilities
present
conflict
may
facilitate
prompt
adequate
psychological
help.
Since
an
antecedent
PTSD
several
autoimmune
disorders,
these
results
also
serve
as
predictor
future
challenges
for
society.